Financials Vericel Corporation

Equities

VCEL

US92346J1088

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
46.05 USD +1.32% Intraday chart for Vericel Corporation +5.28% +29.32%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 777.7 1,403 1,840 1,244 1,699 2,224 - -
Enterprise Value (EV) 1 777.7 1,403 1,840 1,244 1,699 2,224 2,224 2,224
P/E ratio -79.1 x 515 x -246 x -75.3 x -509 x 576 x 94.6 x 52.8 x
Yield - - - - - - - -
Capitalization / Revenue 6.6 x 11.3 x 11.8 x 7.57 x 8.6 x 9.3 x 7.43 x 5.87 x
EV / Revenue 6.6 x 11.3 x 11.8 x 7.57 x 8.6 x 9.3 x 7.43 x 5.87 x
EV / EBITDA -81.8 x 75.5 x 62.4 x 51.4 x 50.2 x 45.8 x 29.7 x 25.5 x
EV / FCF -79,363,660 x 93,860,642 x - 123,263,648 x - - - -
FCF Yield -0% 0% - 0% - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 44,695 45,429 46,815 47,223 47,725 48,290 - -
Reference price 2 17.40 30.88 39.30 26.34 35.61 46.05 46.05 46.05
Announcement Date 2/25/20 2/24/21 2/24/22 2/23/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 117.8 124.2 156.2 164.4 197.5 239.2 299.2 379.1
EBITDA 1 -9.507 18.58 29.48 24.2 33.88 48.5 74.87 87.1
EBIT 1 -11.25 2.372 -7.854 -17.06 -6.464 5.361 27.21 47.95
Operating Margin -9.55% 1.91% -5.03% -10.38% -3.27% 2.24% 9.1% 12.65%
Earnings before Tax (EBT) 1 -9.665 3.044 -7.582 -15.99 -2.368 6.723 28.66 48.08
Net income 1 -9.665 2.864 -7.471 -16.71 -3.182 4.268 25.45 46.62
Net margin -8.2% 2.31% -4.78% -10.17% -1.61% 1.78% 8.51% 12.3%
EPS 2 -0.2200 0.0600 -0.1600 -0.3500 -0.0700 0.0800 0.4867 0.8725
Free Cash Flow -9.799 14.95 - 10.09 - - - -
FCF margin -8.31% 12.04% - 6.14% - - - -
FCF Conversion (EBITDA) - 80.42% - 41.7% - - - -
FCF Conversion (Net income) - 521.86% - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/25/20 2/24/21 2/24/22 2/23/23 2/29/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 34.51 47.59 36.07 37.05 38.55 52.69 41.02 45.92 45.58 65 49.07 54.33 57.02 78.82 60.3
EBITDA 1 4.301 12.77 3.243 2.772 3.325 14.86 1.7 4.441 5.444 22.3 4.742 7.165 8.488 28.11 11.15
EBIT 1 -4.961 4.141 -7.273 -9.082 -6.788 6.085 -8.177 -5.961 -5.057 12.73 -5.495 -2.678 -1.486 15.02 -0.2467
Operating Margin -14.38% 8.7% -20.16% -24.52% -17.61% 11.55% -19.94% -12.98% -11.09% 19.59% -11.2% -4.93% -2.61% 19.06% -0.41%
Earnings before Tax (EBT) 1 -4.931 4.209 -7.091 -8.963 -6.556 6.622 -7.495 -5.02 -3.946 14.09 -5.172 -2.331 -1.14 15.37 0.0867
Net income 1 -4.931 4.535 -7.091 -8.963 -6.577 5.922 -7.495 -5.02 -3.66 12.99 -5.33 -2.654 -1.067 13.32 -0.08
Net margin -14.29% 9.53% -19.66% -24.19% -17.06% 11.24% -18.27% -10.93% -8.03% 19.99% -10.86% -4.89% -1.87% 16.9% -0.13%
EPS 2 -0.1100 0.0900 -0.1500 -0.1900 -0.1400 0.1300 -0.1600 -0.1100 -0.0800 0.2600 -0.1100 -0.0567 -0.0217 0.2583 -0.0320
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/9/21 2/24/22 5/4/22 8/3/22 11/9/22 2/23/23 5/10/23 8/2/23 11/8/23 2/29/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow -9.8 14.9 - 10.1 - - - -
ROE (net income / shareholders' equity) - 2.33% - - - - - -
ROA (Net income/ Total Assets) - 1.6% - - - - - -
Assets 1 - 179.4 - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - 2.63 - 7.6 20 16 10 -
Capex / Sales - 2.11% - 4.62% 10.13% 6.69% 3.34% -
Announcement Date 2/25/20 2/24/21 2/24/22 2/23/23 2/29/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
46.05 USD
Average target price
53.9 USD
Spread / Average Target
+17.05%
Consensus
  1. Stock Market
  2. Equities
  3. VCEL Stock
  4. Financials Vericel Corporation